DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Glenmark Pharmaceuticals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·21 Sept 2026, 9:22 am

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited has announced that it will hold an analyst and institutional investor meet. This is a routine corporate disclosure where the company invites financial experts and large investors to discuss its business performance and future outlook.

For investors, this update is a signal that the company is engaging with the market to share its strategic plans. It provides an opportunity for the management to address key concerns and highlight growth areas, which can help in gauging the sentiment around the stock.

Investors should pay close attention to the management's commentary on their product pipeline, debt levels, and revenue guidance during the call. This information is crucial for assessing the company's operational health and future potential.